| Drug Name: | Phenetidine (156-43-4) |
|---|---|
| PubChem ID: | 9076 |
| SMILES: | CCOC1=CC=C(C=C1)N |
| InchiKey: | IMPPGHMHELILKG-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 137.182 |
| LogP | : | 1.6675 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 35.25 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Respiratory Burst | Myeloperoxidase precursor (P05164) | Myeloperoxidase appears to be much more important in the binding of p-phenetidine to DNA than it is in the DNA binding of arylamines in general@causing the respiratory burst the bioactivation of certain arylamines [ ADR Type 2 3 ] | Metabolic activation and nucleic acid binding of acetaminophen and related arylamine substrates by the respiratory burst of human granulocytes |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Methemoglobinemia | MetaADEDB |